TRVI compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

Compare

TRVITrevi Therapeutics, Inc.

MBXMBX Biosciences, Inc.

Price

Mkt cap

Revenue

Supply-chain overlap

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

direct ties · both sidesSources ›

direct ties · both sides

Only TRVI 2

—Keenova Therapeuticsunlistedsupplier

—Par Healthunlistedsupplier

Shared 0

No shared counterparties.

Only MBX 3

—Dr. Richard DiMarchiunlistedsupplier

—Indiana University Research and Technology Corporation ("IURTC")unlistedsupplier

—Trustees of Indiana Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

TRVITrevi Therapeutics, Inc.

13.86▲+1.69%· post 13.86· delayed

Mkt cap$1.9B

MBXMBX Biosciences, Inc.

55.05▲+1.20%· post 55.05· delayed

After hoursNov 3 '26delayed

Mkt cap$2.6B

Compare

After hoursNov 3 '26delayed

TRVITrevi Therapeutics, Inc.

MBXMBX Biosciences, Inc.

13.86▲+1.69%post 13.86delayed

Price

55.05▲+1.20%post 55.05delayed

$1.9B

Mkt cap

$2.6B

TRVI13.86▲+1.69%vsMBX55.05▲+1.20%After hoursNov 3 '26delayed